Overview Financials News + Filings Key Docs Ownership Insiders
|
In millions, except per share items | Apr-30-23 | Jan-31-23 | Oct-31-22 | Apr-30-22 | Jan-31-22 | Oct-31-21 | Jul-31-21 | Apr-30-21 |
| 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.3 | 0.0 | |
Revenue growth | | | -100.0% | | -100.0% | | | |
Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.3 | 0.0 | |
Gross margin | | | | | | 100.0% | | |
Selling, general and administrative [+] | 0.0 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.2 | |
General and administrative | 0.0 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.2 | |
Research and development | | | | | | -0.4 | 0.2 | |
Other operating expenses | 0.0 | -0.1 | 0.0 | -0.1 | -0.1 | | -0.4 | |
EBITDA [+] | | | | | | | | |
Depreciation and amortization | | | | | | | | |
EBIT [+] | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
EBIT growth | | | -100.0% | | -100.0% | -100.0% | | |
EBIT margin | | | | | | 0.0% | | |
Other income (expense), net | 0.0 | -0.1 | 0.0 | -0.1 | -0.1 | -0.1 | -0.3 | |
Pre-tax income | 0.0 | -0.1 | 0.0 | -0.1 | -0.1 | -0.1 | -0.3 | |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
Net income | 0.0 | -0.1 | 0.0 | -0.1 | -0.1 | -0.1 | -0.3 | |
Net margin | | | | | | 27.1% | | |
|
Basic EPS [+] | $0.02 | $0.00 | ($0.02) | $0.00 | $0.00 | $0.00 | $0.00 | |
Growth | -20886.5% | 1524.2% | 11087.6% | | 2.2% | -91.0% | 14.6% | |
Diluted EPS [+] | $0.02 | $0.00 | ($0.02) | $0.00 | $0.00 | $0.00 | $0.00 | |
Growth | -20886.5% | 1524.2% | 11087.6% | | 2.2% | -91.0% | 14.6% | |
|
Shares outstanding (basic) [+] | 1.3 | 16.1 | 1.1 | 530.7 | 321.5 | 425.6 | 389.0 | |
Growth | -99.8% | -95.0% | -99.8% | | -24.4% | 1486.7% | 126.4% | |
Shares outstanding (diluted) [+] | 1.3 | 16.1 | 1.1 | 530.7 | 321.5 | 425.6 | 389.0 | |
Growth | -99.8% | -95.0% | -99.8% | | -24.4% | 1486.7% | 126.4% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|